ANNEX I, Commission Implementing Regulation (EU) No 564/2013 of 18 June 2013 on the fees and char…

In forcesince 14 Aug 2025cited 1×

[Commission Delegated Regulation (EU) No 1062/2014 of 4 August 2014 on the work programme for the systematic examination of all existing active substances contained in biocidal products referred to in Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 294, 10.10.2014, p. 1, ELI: http://data.europa.eu/eli/reg_del/2014/1062/oj).]

General description of task; relevant provision in Regulation (EU) No 528/2012 | Specific condition or task description | Fee (EUR)

Approval of an active substance; Article 7(2) | Fee for the first product-type for which that active substance is approved | 143400

Additional fee per additional product-type | 47800

Additional fee per product-type (for both the first product-type and any additional product-type) if the active substance is a candidate for substitution in accordance with Article 10 of Regulation (EU) No 528/2012 | 23900

Fee for the amendment of an approval, other than the addition of a product-type | 23900

Renewal of an approval; Article 13(3) | Fee for the first product-type for which renewal of that active substance is sought | 17925

Additional fee per additional product-type | 1793

Additional fee for the first product-type for which renewal of that active substance is sought in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012 | 29875

Additional fee per additional product-type in case a full evaluation is found necessary in accordance with Article 14(1) of Regulation (EU) No 528/2012 | 2988

Additional fee per product-type (for both the first product-type and any additional product-type) if the active substance is a candidate for substitution in accordance with Article 10 of Regulation (EU) No 528/2012 | 23900

Inclusion in Annex I of an active substance; Article 28 | Fee for the first inclusion in Annex I of an active substance | 11950

Fee for the amendment of an inclusion of an active substance in Annex I | 2390

Notification in accordance with Article 17(4) of Commission Delegated Regulation (EU) No 1062/2014 |

Fee per substance/product-type combination.

The fee for the notification shall be deducted from the subsequent application for approval

11950

Type of enterprise | Reduction (% of the standard fee)

Micro enterprise | 60

Small enterprise | 40

Medium enterprise | 20